Spontaneous adverse event reports associated with zolpidem in Australia 2001-2008

Journal of Sleep Research

Volumn 20, Issue 4, 2011, Pages 559-568

  Ben Hamou, Monsif ^a   Marshall, Nathaniel S ^a   Grunstein, Ronald R ^a   Saini, Bandana ^a   Fois, Romano A ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Insomnia; Sleep; Sleepdriving; Sleepwalking

Indexed keywords

BENZODIAZEPINE; HYPNOTIC AGENT; TEMAZEPAM; ZOLPIDEM TARTRATE;

ADVERSE OUTCOME; AMNESIA; ARTICLE; AUSTRALIA; COMORBIDITY; DATA BASE; DISEASE ASSOCIATION; DRUG MONITORING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; HALLUCINATION; HUMAN; INSOMNIA; PRIORITY JOURNAL; SUICIDAL IDEATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AUSTRALIA; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PYRIDINES; RETROSPECTIVE STUDIES; SEX FACTORS; SLEEP INITIATION AND MAINTENANCE DISORDERS; YOUNG ADULT;

EID: 81255149380     PISSN: 09621105     EISSN: 13652869     Source Type: Journal    
DOI: 10.1111/j.1365-2869.2011.00919.x     Document Type: Article

References (33)

1. Australian Adverse Drug Reactions Advisory Committee (ADRAC). Zolpidem and bizarre sleep related effects. Aust. Adv. Drug React. Bull., 2007, 26: 2.
2. Dolder, C. and Nelson, M. Hypnosedative-induced complex behaviours: incidence, mechanisms and management. CNS Drugs, 2008, 22: 1021-1036.
3. Edwards, I. R. and Aronson, J. K. Adverse drug reactions: definitions, diagnosis, and management. Lancet, 2000, 356: 1255-12159.
4. Espie, C. 'Stepped care': a health technology solution for delivering cognitive behavioral therapy as a first line insomnia treatment. Sleep, 2009, 32: 1549-1558.
5. Ganzoni, E., Santoni, J., Chevillard, V., Sébille, M. and Mathy, B. Zolpidem in insomnia: a 3-year post-marketing surveillance study in Switzerland. J. Int. Med. Res., 1995, 23: 61-73.
6. Hajak, G. and Bandelow, B. Safety and tolerance of zolpidem in the treatment of disturbed sleep: a post-marketing surveillance of 16944 cases. Int. Clin. Psychopharmacol., 1998, 13: 157-167.
7. Hollingworth, S. A. and Siskind, D. J. Anxiolytic, hypnotic and sedative medication use in Australia. Pharmacoepidemiol. Drug Saf., 2010, 19: 280-288.
8. Hoque, R. and Chesson, A. Zolpidem-induced sleepwalking, sleep related eating disorder, and sleep-driving: fluorine-18-flourodeoxyglucose positron emission tomography analysis, and a literature review of other unexpected clinical effects of zolpidem. J. Clin. Sleep Med., 2009, 5: 471-476.
9. Hwang, T.-J., Ni, H.-C., Chen, H.-C., Lin, Y.-T. and Liao, S.-C. Risk predictors for hypnosedative-related complex sleep behaviors: a retrospective, cross-sectional pilot study. J. Clin. Psychiatry, 2010, 71: 1331-1335.
10. Institute of Medicine (USA). Sleep Disorders and Sleep Deprivation: An Unmet Public Health Problem. Institute of Medicine, Washington, DC, 2006.
11. Landolt, H.-P., Roth, C., Dijk, D.-J. and Borbely, A. A. late-afternoon ethanol intake affects nocturnal sleep and the sleep EEG in middle-aged men. J. Clin. Psychopharmacol., 1996, 16: 428-436.
12. Landolt, H. P., Finelli, L. A., Roth, C., Buck, A., Achermann, P. and Borbély, A. A. Zolpidem and sleep deprivation: different effect on EEG power spectra. J. Sleep Res., 2000, 9: 175-183.
13. Li, S., Zhang, B., Li, A. and Wing, Y. Prevalence and correlates of frequent nightmares: a community-based 2-phase study. Sleep, 2010, 33: 774-780.
14. Mancini, J., Thirion, X., Masut, A. et al. Anxiolytics, hypnotics, and antidepressants dispensed to adolescents in a French region in 2002. Pharmacoepidemiol. Drug Saf., 2006, 15: 494-503.
15. Markowitz, J. S. and Brewerton, T. D. Zolpidem-induced psychosis. Ann. Clin. Psychiatry, 1996, 8: 89-91.
16. Matwiyoff, G. and Lee-Chiong, T. Parasomnias: an overview. Ind. J. Med. Res., 2010, 131: 333-337.
17. Mendelson, W. B. Sleepwalking associated with zolpidem. J. Clin. Psychopharmacol., 1994, 14: 150.
18. Monti, J., Alvariño, F. and Monti, D. Conventional and power spectrum analysis of the effects of zolpidem on sleep EEG in patients with chronic primary insomnia. Sleep, 2000, 23: 1075-1084.
19. Morgenthaler, T. I. and Silber, M. H. Amnestic sleep-related eating disorder associated with zolpidem. Sleep Med., 2002, 3: 323-327.
20. Morin, C. M., Vallieres, A., Guay, B. et al. Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial. JAMA, 2009, 301: 2005-2015.
21. NIH Statement Regarding Treatment of Insomnia. National Institutes of Health State of the Science Conference Statement on Manifestations and Management of Chronic Insomnia in Adults. Sleep, 2005, 28: 1049-1057.
22. Olson, L. Hypnotic hazards: adverse effects of zolpidem and other z-drugs. Aust. Prescriber, 2008, 31: 146-149.
23. Ozminkowski, R., Wang, S. and Walsh, J. The direct and indirect costs of untreated insomnia in adults in the United States. Sleep, 2007, 30: 263-273.
24. Pressman, M. R., Mahowald, M. W., Schenck, C. H. and Bornemann, M. C. No scientific evidence that alcohol causes sleepwalking. J. Sleep Res., 2008, 17: 473-474.
25. Roy, A. N. and Smith, M. Prevalence and cost of insomnia in a state Medicaid fee-for-service population based on diagnostic codes and prescription utilization. Sleep Med., 2010, 11: 462-469.
26. Salmerón-García, A., Barrera, J., Pavón, M. et al. Detection of adverse drug reactions through the minimum basic data set. Pharm. World Sci., 2010, 33: 322-328.
27. Sauvanet, J., Maarek, L., Roger, M., Renaudin, J., Louvel, E. and Orofiamma, B. Open long-term trials with zolpidem in insomnia. In: J. Sauvanet, S. Langer and P. Morselli (Eds) Imidazopyridines in Sleep Disorders. Raven Press, New York, 1988: 339-349.
28. Schenck, C., Connoy, D. and Castellanos, M. Zolpidem-induced sleep related eating disorder (SRED) in 19 patients. Sleep, 2005, 28: A259.
29. Schutte-Rodin, S., Broch, L., Buysse, D., Dorsey, C. and Sateia, M. Clinical guideline for the evaluation and management of chronic insomnia in adults. J. Clin. Sleep Med., 2008, 4: 487-504.
30. Simon, G. and Vonkorff, M. Prevalence, burden, and treatment of insomnia in primary care. Am. J. Psychiatry, 1997, 154: 1417-1423.
31. Tsai, J.-H., Yang, P., Chen, C.-C. et al. Zolpidem-induced amnesia and somnambulism: rare occurrences? Eur. Neuropsychopharmacol., 2009, 19: 74-76.
32. Van Puijenbroek, E. P., Bate, A., Leufkens, H. G. M., Lindquist, M., Orre, R. and Egberts, A. C. G. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol. Drug Saf., 2002, 11: 3-10.
33. Wing, Y., Lam, S., Li, S., Zhang, J. and Yu, M. Sleep-related eating disorder and zolpidem: an open interventional cohort study. J. Clin. Psychiatry, 2010, 71: 653-656.